Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci;A grubu beta-hemolitik streptokoklarda eritromisin direnç oranlarιnιn ve direnç fenotipinin araştιrιlmasι

Mikrobiyoloji Bulteni

Volumn 40, Issue 3, 2006, Pages 161-168

  Gündüz Kaya, Esma ^a   Yücel, Mihriban ^a   Karakoç, A Esra ^a  

^a Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali   (Turkey)

Author keywords

Erythromycin resistance; Group A beta haemolytic streptococci; Resistance phenotype

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHARYNX; PHENOTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PHARYNX; PHENOTYPE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 39049191697     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. The Color Atlas and Textbook of Diagnostic Microbiology, p 577-603. 1997, 5th ed. JB Lippincott Co, Philadelphia.
2. Steigbigel HN. Macrolides and clindamycin, p: 366-78. In: Mandell GL, Bennet JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 2000, 5th ed. Churchill Livingstone, Philadelphia.
3. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34: 482-92.
4. Alos JI, Aracil B, Oteo J, Gomez-Garces JL. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. J Antimicrob Chemother 2003; 51: 333-7.
5. Sauermann R, Gattringer R, Graninger W, Buxbaum A, Georgopoulos A. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics. J Antimicrob Chemother 2003; 51: 53-7.
6. Hsueh PR, Teng LJ, Lee CM, et al. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data. Antimicrob Agents Chemother 2003; 47: 2152-7.
7. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995; 39: 577-85.
8. Berkiten R. Streptococcus pyogenes suglarinda eritromisin direnç fenotipleri ve 1970-2001 yillan arasinda Türkiye'de izole edilen suşlarda direnç. Ankem Derg 2003, 17: 429-34.
9. Clancy J, Petitpas J, Dib-Hajj F, et al. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol 1996, 22: 867-79.
10. Seppala H, Nissinen A, Quan Y, Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993; 32: 885-91.
11. Bingen E, Leclercq R, Fitoussi F, Brahimi N, Malbruny B, Deforche D, Cohen R. Emergence of group A streptococcus strains with different mechanisms of macrolide resistance. Antimicrob Agents Chemother 2002; 46: 1199-203.
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard, 2003, 6th, ed. NCCLS Document M7-A6. NCCLS, Wayne, Pa.
13. Waites K, Johnson C, Gray B, Edwards K, Crain M, Benjamin W. Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. J Clin Microbiol 2000; 38:1731-4.
14. Bingen E, Fitoussi F, Doit C, et al. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother 2000; 44: 1453-7.
15. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Martin JE. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol 2002; 40: 2959-63.
16. Portillo A, Lantero M, Gastanares MJ, Ruiz-Larrea F, Torres C. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. Int J Antimicrob Agents 1999; 13: 137.
17. Borzani M, De Luca M, Varotto F. A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy. J Antimicrob Chemother 1997 40: 457-8.
18. Cornaglia G, Ligozzi M, Mazzariol A, Masala L, Lo Cascio G, Orefici G. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin Infect Dis 1998; 27: 87-92.
19. Rondini G, Cocuzza Ce, Cianflone M, Lanzafame A, Santini L, Mattini R. Bacteriological and clinical efficacy of various antibiotics used in the treatment of streptococcal pharyngitis in Italy. Int J Antimicrob Agents 2001; 18: 9.
20. Weber P, Filipecki J, Bingen E, et al. Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J Antimicrob Chemother 2001; 48: 291.
21. Cullmann W. Comparative evaluation of orally active antibiotics against community-acquired pathogens: results of eight European countries. Chemotherapy 1996, 42: 11-20.
22. Kataja J, Huovinen P, Muotiala A, Vuopio-Varkila J, Efstratiou A, Hallas G, The Finnish Study Group for Antimicrobial Resistance, Seppala H. Clonal spread of group A Streptococcus with the new type of erythromycin-resistance. J Infect Dis 1998; 177: 786-9.
23. Detcheva A, Facklam RR, Beall B. Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2002. J Clin Microbiol 2002; 40: 3831-4.
24. Petinaki E, Kontos F, Pratti A, Skulakis C, Maniatis AN. Clinical isolates of macrolide-resistant Streptococcus pyogenes in central Greece. Int J Antimicrob Agents 2003; 21: 67-70.
25. Syrogiannopoulos GA, Grivea IN, Fitoussi F, et al. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. Pediatr Infect Dis J 2001; 20: 863.
26. Palavecino EL, Riedel I, Berrios X, et al. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrob Agents Chemother 2001; 45: 339-41.
27. Wittler RR, Yamada SM, Bass JW, Hamill R, Wiebe RA, Ascher DP. Penicillin tolerance and erythromycin resistance of group A beta hemolytic streptococci in Hawaii and Philippines. Am J Dis Child 1990; 144: 587-9.
28. Yan JJ, Wu HM, Huang AH, Fu HM, Lee CT, Wu JJ. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in southern Taiwan. J Clin Microbiol 2000; 38: 2475.
29. Maruyama S, Yoshioka H, Fujita K, Takimoto M, Sarake Y. Sensitivity of group A streptococci to antibiotics. Am J Dis Child 1979; 133: 1143.
30. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441-6.
31. Erdoǧan H, Öngen B, Öksüz L, Gürler N, Töreci K. A grubu beta-hemolitik streptokoklarda antibiyotik direnci ve makrolid direnç fenotipinin saptanmasi. Ankem Derg 2003; 17: 85-87.
32. Şenses Z, Baysallar M, Gür D, Doǧanci L. 1999-2000 ve 2001-2002 ylllanna ait grup A beta hemolitilk streptokok izolatlannin makrolid antibiyotiklere direnç oranlan ve fenotipleri. Mikrobiyol Bül 2003; 37: 225-34.
33. Tunçkanat F, Şener B, Akan Ö, Berkman E. A grubu beta-hemolitik streptokoklara bazi makrolid antibiyotiklerin in-vitro etkileri. Ankem Derg 1993; 239-42.
34. Gürsoy HG, Çöplü N, Zarakolu P, Ulumlu G, Özkaya E, Güvener E. Grup A beta-hemolitik streptokoklann eritromisine in-vitro duyarliliklarinin araştirilmasi. Ankem Derg 1994; 8: 23-5.
35. Kaloǧlu G, Tuncer I, Baysal B. Boǧaz kültürlerinden izole edilen A grubu beta hemolitik streptokoklarda penisilin toleransi ve eritromisin direncinin araştirilmasi. Mikrobiyol Bült 1998; 32: 9-13.
36. Er E, Akdoǧan M, Köksal F, Gümüş M, Samasti M, Özdemir A. Boǧaz kültüründe üretilen betahemolitik streptokoklar ve antibiyotiklere duyarliliklari. Inteks Derg 2000; 14: 519-21.
37. Karakeçe E, Taşçioǧlu J. A grubu beta hemolitik streptokoklarda penisilin toleransi ve eritromisin direncinin araştirilmasi. Flora 2000; 5: 56-60.
38. Yavuzdemir Ş, Bengisun JS. Boǧaz kültürlerinden izole edilen beta hemolitik streptokok gruplan ve antibiyotiklere duyarliliklarin araştirilmasi. Mikrobiyol Bült 1997; 31: 149-53.